首页 正文

Promising response to neoadjuvant pembrolizumab and low-dose chemotherapy in advanced endometrial cancer: A preliminary report

{{output}}
Objective: Recent trials demonstrated improved outcomes with immunotherapy-chemotherapy combinations in advanced endometrial cancer (EC) with mismatch repair deficiency (dMMR). We evaluated clinical characteristics, treatment res... ...